Melnick
SL, Sprafka JM, Laitinen DL, Bostick RM, Flack JM, Burke GL.
Antiobiotic use in urban whites and blacks: the Minnesota Heart Survey.
Ann Pharmacother 1992;26(10):1292-5.
This study tested the hypothesis that there are differences between whites
and blacks with regard to the frequency and types of antibiotics used.
Because of their high prescription rate and stability, as well as the
fact that they are not available over-the-counter, systemic antibiotics
are useful indicators of racial differences in overall patterns of medication
use.
Data were collected from subjects enrolled in the Minnesota Heart Survey,
which consisted of two probability samples of residents in the Twin Cities
metropolitan area in 1980-1982 and in 1985-1987. Subjects were asked to
report on medication use, including antibiotic medication use.
Statistically significant racial differences in the prevalence of antibiotic
use were found for several demographic and diagnostic categories. In sum,
when there were racial differences, whites reported higher rates of antibiotic
use. After age adjustment, 22% of whites and 17% of blacks used antibiotics.
Adjusted for age, the race and gender results were as follows: 15% of
black men, 18% of white men, 18% of black women, and 26% of white women
used antibiotics. With regard to specific types of antibiotics, white
men reported greater use of penicillin, erythromycins, and cephalosporin
in the year preceding the survey. Black men were more than twice as likely
to report sulfa use (despite the fact that sulfa drugs are contraindicated
in the presence of glucose-6-phosphate deficiency, an inborn error of
metabolism that affects 10% of U.S. black men). White women were more
likely to reported use for all drug classes.
The authors state that this difference in antibiotic medication use is
probably not explained by differences in healthcare utilization, as the
average annual number of physician visits in the U.S. was similar for
all racial groups from 1978 to 1980 (according to the Report of the Secretary's
Task Force on Black and Minority Health, 1985). The authors note that
it is not possible to determine from these data if these differences reflected
only patient compliance with having prescriptions filled or taking the
medications. Other possible explanations were not offered, but the authors
do caution that it is important to determine whether these patterns are
consistent for other types of medications and conclude that the observed
differences "may influence overall health by increasing or prolonging
morbidity, thereby increasing healthcare costs overall."